Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study

被引：0
作者：
Keitaro Yokoyama
Teruo Hashimoto
Yuri Okuda
Yu Matsumoto
Kyoko Ito
Ryoichi Yamada
Hiroyuki Susai
Noriaki Nishino
机构：
[1] The Jikei University School of Medicine,Department of Health Science, The Graduate School
[2] Pharmaceutical Division,Medical Affairs Department
[3] Japan Tobacco Inc.,Pharmacovigilance Department
[4] Torii Pharmaceutical Co.,undefined
[5] Ltd,undefined
[6] Torii Pharmaceutical Co.,undefined
[7] Ltd,undefined
[8] Harumi Triton Clinic of The Jikei University Hospital Harumi Island Triton Square Office Tower,undefined
来源：
Clinical and Experimental Nephrology | 2022年 / 26卷
关键词：
Ferric citrate; Chronic kidney disease; Hyperphosphatemia; Dialysis; Non-dialysis-dependent; Long-term safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：688 / 699
页数：11
相关论文
共 27 条
  • [1] Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study
    Yokoyama, Keitaro
    Hashimoto, Teruo
    Okuda, Yuri
    Matsumoto, Yu
    Ito, Kyoko
    Yamada, Ryoichi
    Susai, Hiroyuki
    Nishino, Noriaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (07) : 688 - 699
  • [2] Effects of ferric citrate hydrate in patients with chronic kidney disease and heart failure: subgroup analysis of a long-term, real-world, post-marketing surveillance study
    Ito, Kyoko
    Murakami, Kenjiro
    Yamada, Ryoichi
    Susai, Hiroyuki
    Nishino, Noriaki
    RENAL REPLACEMENT THERAPY, 2022, 8 (01)
  • [3] Real-world safety and effectiveness of roxadustat in patients with anemia of chronic kidney disease: interim results from a post-marketing surveillance study in Japan
    Tsuruya, Kazuhiko
    Sugamori, Haruko
    Tanaka, Yusuke
    Wakasugi, Naoko
    Ito, Yuichiro
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (04) : 503 - 517
  • [4] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Ikeda, Rie
    Ochiai, Kaori
    Hirase, Tetsuaki
    Hayashi, Naoyuki
    Okamura, Tomoo
    DIABETES THERAPY, 2020, 11 (02) : 523 - 533
  • [5] Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease-A Real-World Experience
    Pereira, Sara C.
    Rodrigues, Tiago
    Nunes-Ferreira, Afonso
    Agostinho, Joao R.
    Pinto, Fausto J.
    Brito, Dulce
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [6] Chronic kidney disease in acute coronary syndromes: real-world data of long-term outcomes
    Saleiro, Carolina
    Puga, Luis
    De Campos, Diana
    Lopes, Joao
    Sousa, Jose P.
    Gomes, Ana Rita M.
    Costa, Marco
    Teixeira, Rogerio
    Goncalves, Lino
    FUTURE CARDIOLOGY, 2021, 17 (08) : 1359 - 1370
  • [7] Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy
    Kumar, Rakesh
    Joseph, Boney
    Pazdernik, Vanessa M.
    Geske, Jennifer
    Nunez, Nicolas A.
    Pahwa, Mehak
    Kashani, Kianoush B.
    Veldic, Marin
    Betcher, Hannah K.
    Moore, Katherine M.
    Croarkin, Paul E.
    Ozerdem, Aysegul
    Cuellar-Barboza, Alfredo B.
    McElroy, Susan L.
    Biernacka, Joanna M.
    Frye, Mark A.
    Singh, Balwinder
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (01) : 6 - 11
  • [8] Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease
    Sinakos, E.
    Panas, P.
    Fragkou, N.
    Antoniadis, N.
    Katsanos, G.
    Tsakni, E.
    Oikonomou, T.
    Notopoulos, A.
    Tsoulfas, G.
    Goulis, I
    Akriviadis, E.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2022, 85 (02) : 331 - 337
  • [9] Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
    Sinha, Shubhadeep D.
    Bandi, Vamsi K.
    Reddy, Bala B.
    Thakur, Pankaj
    Chary, Sreenivasa
    Talluri, Leela
    Kakkunnath, Sheejith
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [10] Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT)
    Utsunomiya, Kazunori
    Koshida, Ryusuke
    Kakiuchi, Seigo
    Senda, Masayuki
    Fujii, Shoko
    Kurihara, Yuji
    Gunji, Ryoji
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (02) : 184 - 199
123